"Lecture-casts"- A Lecture Series on General Chemistry

In this episode of \" \"Lecture-casts\"- A Podcast Lecture Series in General Chemistry\", we highlight an interview with Dr. Emery Brown, MD, PhD - Harvard/ MIT - in English and with the Portuguese Translation Afterwards.

---Dr. Emery Brown, MD, PhD- Interview Transcript:https://thenewchemistpublications.pubpub.org/pub/829eb62b/release/1

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of \" \"Lecture-casts\"- A Podcast Lecture Series in General Chemistry\", we highlight an interview with Dr. Emery Brown, MD, PhD - Harvard/ MIT - in English and with the Spanish Translation Afterwards.

---Dr. Emery Brown, MD, PhD- Interview Transcript:https://thenewchemistpublications.pubpub.org/pub/829eb62b/release/1

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of \"Lecture-casts\"- A Podcast Lecture Series in General Chemistry, we have a S.T.E.A.M. interview with Lynreshay Johnson, M.A. , we discuss her passion for the arts and how arts can be a conduit to teach complicated concepts and help people find deeper meaning.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Interview with Dr. Emery Brown, MD, PhD - Harvard/ MIT - In English and with French Translation Afterwards.

---

Dr. Emery Brown, MD, PhD- Interview Transcript:

https://thenewchemistpublications.pubpub.org/pub/829eb62b/release/1

Learn more about your ad choices. Visit megaphone.fm/adchoices

On this podcast, we discuss and talk about in real-time foundational concepts associated with, preparing for the MCAT. Each episode is about 1hr- 1hr and 35 minutes. The goal of this podcast is to go alongside people on their pre-med journey. You matter and your desire to help people matters. Be hopefully realistic, encouraged, motivated, and inspired. You can do it! This podcast has no affiliation with the AAMC. It is affiliated with The New Chemist Podcast and is solely a supplement for test preparation. The views of this podcast represent those solely of the host and guest.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of \" \" Lecture-casts\"- A Podcast Lecture Series in General Chemistry\" , I highlight an episode from \"The New Chemist\'s Podcast\", in which I presented my Undergraduate Thesis on the Total Synthesis of Vitamin B-12 ( Eschenmoser Variant) . This is a flashback to my time at Taylor University! Definitely a good episode!

Learn more about your ad choices. Visit megaphone.fm/adchoices

This is one of the top recommended episodes for those transitioning to Organic Chemistry 1. Good Luck !

---

Organic Chemistry Introductions- Video Episode! Remember:

1. Non-aromatic- Not cyclic and not planar.

2. Anti-aromatic refers to  4n pi- electrons , as opposed to 4n+2 pi electrons  which obeys Huckel\'s rule.

---

*Correction Notes: 1. for Mnemonic for some heterocycles :  ( -ir,-et, -ol, -, ep )- referring to oxirane, oxetane, oxolane, oxane and oxeptane.

2. Butane - C4H10

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, I reflect on a keystone moment in graduate school, within which I worked on my graduate thesis that was centered around the significance of a phospholipid (cardiolipin) in neurodegenerative diseases, and the potential of that lipid using lipidomics to help further research endeavours.

---

The information contained within this episode is the exclusive work product of David Ferguson and is not to be reproduced, copied or distributed without the expressed written consent of David Joshua Ferguson.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Highlights from The New Chemist\'s Podcast- Interview with Dr. L.C. Campeau - Associate Vice President and Head of Small Molecule R&D at Merck- Video Episode.

---

In this interview we discuss with a leading pioneer in chemistry, Dr. L.C. Campeau, his career and his accomplishments thus far, and what has been an impetus for his achievements. Dr. L.C. Campeau is also a Fellow of the Royal Society of Canada.

--

Dr. Campeau\'s Biography:

L.-C. Campeau obtained his Ph. D. degree in 2007 with the late Professor Keith Fagnou at the University of Ottawa in Canada as an NSERC Doctoral Fellow, after completing his B.Sc. in Biopharmaceutical Sciences. He was the recipient of the Pierre Laberge Prize for the best Ph.D. thesis in the Science Faculty. The Faculty of Science awarded him the inaugural Young Alumni Award in 2016 and in 2022 he received the inaugural Department of Chemistry and Biomolecular Sciences Distinguished Alumni Award. L.-C. first joined Merck Research Laboratories at Merck-Frosst in Montreal in 2007 making key contributions to the discovery of Doravirine (MK-1439) for which he received a Merck Special Achievement Award. In 2010, he moved from Quebec to New Jersey, where he has served in roles of increasing responsibility Head of Catalysis & Automation, Head of Discovery Process Chemistry and Head of Process Chemistry. L.-C. is currently Associate Vice President and the Head of Small Molecule Process Research and Development, leading a team of smart creative scientists and engineers developing innovative solutions in support of all discovery, pre-clinical and clinical active pharmaceutical ingredient deliveries for the entire Merck portfolio for small-molecule therapeutics. Over his tenure at Merck, L.-C. and his team have made important contributions to >40 clinical candidates and 7 commercial products to date. Under his leadership, his organization has received the EPA’s Green Chemistry Challenge Award four consecutive years and received the Heroes of Chemistry Award for their work on Molnupiravir in 2022. His passion for scientific excellence exemplified by >80 publications and patents, several successful collaborations with key academics, and an extensive list of >85 invited lectures worldwide. As a proud Canadian, L.-C. continues his engagement in the Canadian chemistry community, serving 4 years on the NSERC Discovery Grants committee (2019-2022) and currently sits on the NSERC National Awards Selection Committee. L.-C. was elected Fellow of the Royal Society of Canada in 2022.

Learn more about your ad choices. Visit megaphone.fm/adchoices

In this interview we discuss with a leading pioneer in chemistry, Dr. L.C. Campeau, his career and his accomplishments thus far, and what has been an impetus for his achievements. Dr. L.C. Campeau is also a Fellow of the Royal Society of Canada.

--

Dr. Campeau\'s Biography:

L.-C. Campeau obtained his Ph. D. degree in 2007 with the late Professor Keith Fagnou at the University of Ottawa in Canada as an NSERC Doctoral Fellow, after completing his B.Sc. in Biopharmaceutical Sciences. He was the recipient of the Pierre Laberge Prize for the best Ph.D. thesis in the Science Faculty. The Faculty of Science awarded him the inaugural Young Alumni Award in 2016 and in 2022 he received the inaugural Department of Chemistry and Biomolecular Sciences Distinguished Alumni Award. L.-C. first joined Merck Research Laboratories at Merck-Frosst in Montreal in 2007 making key contributions to the discovery of Doravirine (MK-1439) for which he received a Merck Special Achievement Award. In 2010, he moved from Quebec to New Jersey, where he has served in roles of increasing responsibility Head of Catalysis & Automation, Head of Discovery Process Chemistry and Head of Process Chemistry. L.-C. is currently Associate Vice President and the Head of Small Molecule Process Research and Development, leading a team of smart creative scientists and engineers developing innovative solutions in support of all discovery, pre-clinical and clinical active pharmaceutical ingredient deliveries for the entire Merck portfolio for small-molecule therapeutics. Over his tenure at Merck, L.-C. and his team have made important contributions to >40 clinical candidates and 7 commercial products to date. Under his leadership, his organization has received the EPA’s Green Chemistry Challenge Award four consecutive years and received the Heroes of Chemistry Award for their work on Molnupiravir in 2022. His passion for scientific excellence exemplified by >80 publications and patents, several successful collaborations with key academics, and an extensive list of >85 invited lectures worldwide. As a proud Canadian, L.-C. continues his engagement in the Canadian chemistry community, serving 4 years on the NSERC Discovery Grants committee (2019-2022) and currently sits on the NSERC National Awards Selection Committee. L.-C. was elected Fellow of the Royal Society of Canada in 2022.

Learn more about your ad choices. Visit megaphone.fm/adchoices